Global and Japan Pediatric Medicines Market Insights, Forecast to 2026

Global and Japan Pediatric Medicines Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Pediatric Medicines Product Introduction
1.2 Market Segments
1.3 Key Pediatric Medicines Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Pediatric Medicines Market Size Growth Rate by Type
1.4.2 Enteral
1.4.3 Parenteral
1.4.4 Topical
1.5 Market by Application
1.5.1 Global Pediatric Medicines Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Family
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Pediatric Medicines Market Size, Estimates and Forecasts
2.1.1 Global Pediatric Medicines Revenue 2015-2026
2.1.2 Global Pediatric Medicines Sales 2015-2026
2.2 Global Pediatric Medicines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Pediatric Medicines Historical Market Size by Region (2015-2020)
2.3.1 Global Pediatric Medicines Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Pediatric Medicines Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Pediatric Medicines Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Pediatric Medicines Sales Forecast by Region (2021-2026)
2.4.2 Global Pediatric Medicines Revenue Forecast by Region (2021-2026)
3 Global Pediatric Medicines Competitor Landscape by Players
3.1 Global Top Pediatric Medicines Sales by Manufacturers
3.1.1 Global Pediatric Medicines Sales by Manufacturers (2015-2020)
3.1.2 Global Pediatric Medicines Sales Market Share by Manufacturers (2015-2020)
3.2 Global Pediatric Medicines Manufacturers by Revenue
3.2.1 Global Pediatric Medicines Revenue by Manufacturers (2015-2020)
3.2.2 Global Pediatric Medicines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Pediatric Medicines Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Pediatric Medicines Revenue in 2019
3.2.5 Global Pediatric Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Pediatric Medicines Price by Manufacturers
3.4 Global Pediatric Medicines Manufacturing Base Distribution, Product Types
3.4.1 Pediatric Medicines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pediatric Medicines Product Type
3.4.3 Date of International Manufacturers Enter into Pediatric Medicines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Pediatric Medicines Market Size by Type (2015-2020)
4.1.1 Global Pediatric Medicines Sales by Type (2015-2020)
4.1.2 Global Pediatric Medicines Revenue by Type (2015-2020)
4.1.3 Pediatric Medicines Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Pediatric Medicines Market Size Forecast by Type (2021-2026)
4.2.1 Global Pediatric Medicines Sales Forecast by Type (2021-2026)
4.2.2 Global Pediatric Medicines Revenue Forecast by Type (2021-2026)
4.2.3 Pediatric Medicines Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Pediatric Medicines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Pediatric Medicines Market Size by Application (2015-2020)
5.1.1 Global Pediatric Medicines Sales by Application (2015-2020)
5.1.2 Global Pediatric Medicines Revenue by Application (2015-2020)
5.1.3 Pediatric Medicines Price by Application (2015-2020)
5.2 Pediatric Medicines Market Size Forecast by Application (2021-2026)
5.2.1 Global Pediatric Medicines Sales Forecast by Application (2021-2026)
5.2.2 Global Pediatric Medicines Revenue Forecast by Application (2021-2026)
5.2.3 Global Pediatric Medicines Price Forecast by Application (2021-2026)
6 Japan by Players, Type and Application
6.1 Japan Pediatric Medicines Market Size YoY Growth 2015-2026
6.1.1 Japan Pediatric Medicines Sales YoY Growth 2015-2026
6.1.2 Japan Pediatric Medicines Revenue YoY Growth 2015-2026
6.1.3 Japan Pediatric Medicines Market Share in Global Market 2015-2026
6.2 Japan Pediatric Medicines Market Size by Players (International and Local Players)
6.2.1 Japan Top Pediatric Medicines Players by Sales (2015-2020)
6.2.2 Japan Top Pediatric Medicines Players by Revenue (2015-2020)
6.3 Japan Pediatric Medicines Historic Market Review by Type (2015-2020)
6.3.1 Japan Pediatric Medicines Sales Market Share by Type (2015-2020)
6.3.2 Japan Pediatric Medicines Revenue Market Share by Type (2015-2020)
6.3.3 Japan Pediatric Medicines Price by Type (2015-2020)
6.4 Japan Pediatric Medicines Market Estimates and Forecasts by Type (2021-2026)
6.4.1 Japan Pediatric Medicines Sales Forecast by Type (2021-2026)
6.4.2 Japan Pediatric Medicines Revenue Forecast by Type (2021-2026)
6.4.3 Japan Pediatric Medicines Price Forecast by Type (2021-2026)
6.5 Japan Pediatric Medicines Historic Market Review by Application (2015-2020)
6.5.1 Japan Pediatric Medicines Sales Market Share by Application (2015-2020)
6.5.2 Japan Pediatric Medicines Revenue Market Share by Application (2015-2020)
6.5.3 Japan Pediatric Medicines Price by Application (2015-2020)
6.6 Japan Pediatric Medicines Market Estimates and Forecasts by Application (2021-2026)
6.6.1 Japan Pediatric Medicines Sales Forecast by Application (2021-2026)
6.6.2 Japan Pediatric Medicines Revenue Forecast by Application (2021-2026)
6.6.3 Japan Pediatric Medicines Price Forecast by Application (2021-2026)
7 North America
7.1 North America Pediatric Medicines Market Size YoY Growth 2015-2026
7.2 North America Pediatric Medicines Market Facts & Figures by Country
7.2.1 North America Pediatric Medicines Sales by Country (2015-2020)
7.2.2 North America Pediatric Medicines Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Pediatric Medicines Market Size YoY Growth 2015-2026
8.2 Europe Pediatric Medicines Market Facts & Figures by Country
8.2.1 Europe Pediatric Medicines Sales by Country
8.2.2 Europe Pediatric Medicines Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Pediatric Medicines Market Size YoY Growth 2015-2026
9.2 Asia Pacific Pediatric Medicines Market Facts & Figures by Country
9.2.1 Asia Pacific Pediatric Medicines Sales by Region (2015-2020)
9.2.2 Asia Pacific Pediatric Medicines Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Pediatric Medicines Market Size YoY Growth 2015-2026
10.2 Latin America Pediatric Medicines Market Facts & Figures by Country
10.2.1 Latin America Pediatric Medicines Sales by Country
10.2.2 Latin America Pediatric Medicines Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Pediatric Medicines Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Pediatric Medicines Market Facts & Figures by Country
11.2.1 Middle East and Africa Pediatric Medicines Sales by Country
11.2.2 Middle East and Africa Pediatric Medicines Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 GSK
12.1.1 GSK Corporation Information
12.1.2 GSK Description and Business Overview
12.1.3 GSK Sales, Revenue and Gross Margin (2015-2020)
12.1.4 GSK Pediatric Medicines Products Offered
12.1.5 GSK Recent Development
12.2 Novartis
12.2.1 Novartis Corporation Information
12.2.2 Novartis Description and Business Overview
12.2.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Novartis Pediatric Medicines Products Offered
12.2.5 Novartis Recent Development
12.3 Pfizer
12.3.1 Pfizer Corporation Information
12.3.2 Pfizer Description and Business Overview
12.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Pfizer Pediatric Medicines Products Offered
12.3.5 Pfizer Recent Development
12.4 Sanofi
12.4.1 Sanofi Corporation Information
12.4.2 Sanofi Description and Business Overview
12.4.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Sanofi Pediatric Medicines Products Offered
12.4.5 Sanofi Recent Development
12.5 Abbott
12.5.1 Abbott Corporation Information
12.5.2 Abbott Description and Business Overview
12.5.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Abbott Pediatric Medicines Products Offered
12.5.5 Abbott Recent Development
12.6 Bristol-Myers Squibb
12.6.1 Bristol-Myers Squibb Corporation Information
12.6.2 Bristol-Myers Squibb Description and Business Overview
12.6.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Bristol-Myers Squibb Pediatric Medicines Products Offered
12.6.5 Bristol-Myers Squibb Recent Development
12.7 Cipla
12.7.1 Cipla Corporation Information
12.7.2 Cipla Description and Business Overview
12.7.3 Cipla Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Cipla Pediatric Medicines Products Offered
12.7.5 Cipla Recent Development
12.8 Eisai Pharmaceuticals
12.8.1 Eisai Pharmaceuticals Corporation Information
12.8.2 Eisai Pharmaceuticals Description and Business Overview
12.8.3 Eisai Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Eisai Pharmaceuticals Pediatric Medicines Products Offered
12.8.5 Eisai Pharmaceuticals Recent Development
12.9 Eli Lilly
12.9.1 Eli Lilly Corporation Information
12.9.2 Eli Lilly Description and Business Overview
12.9.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Eli Lilly Pediatric Medicines Products Offered
12.9.5 Eli Lilly Recent Development
12.10 F. Hoffman-La Roche
12.10.1 F. Hoffman-La Roche Corporation Information
12.10.2 F. Hoffman-La Roche Description and Business Overview
12.10.3 F. Hoffman-La Roche Sales, Revenue and Gross Margin (2015-2020)
12.10.4 F. Hoffman-La Roche Pediatric Medicines Products Offered
12.10.5 F. Hoffman-La Roche Recent Development
12.11 GSK
12.11.1 GSK Corporation Information
12.11.2 GSK Description and Business Overview
12.11.3 GSK Sales, Revenue and Gross Margin (2015-2020)
12.11.4 GSK Pediatric Medicines Products Offered
12.11.5 GSK Recent Development
12.12 Helsinn Healthcare
12.12.1 Helsinn Healthcare Corporation Information
12.12.2 Helsinn Healthcare Description and Business Overview
12.12.3 Helsinn Healthcare Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Helsinn Healthcare Products Offered
12.12.5 Helsinn Healthcare Recent Development
12.13 Heron Therapeutics
12.13.1 Heron Therapeutics Corporation Information
12.13.2 Heron Therapeutics Description and Business Overview
12.13.3 Heron Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Heron Therapeutics Products Offered
12.13.5 Heron Therapeutics Recent Development
12.14 Ipca Laboratories
12.14.1 Ipca Laboratories Corporation Information
12.14.2 Ipca Laboratories Description and Business Overview
12.14.3 Ipca Laboratories Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Ipca Laboratories Products Offered
12.14.5 Ipca Laboratories Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Pediatric Medicines Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Pediatric Medicines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Pediatric Medicines Market Segments
Table 2. Ranking of Global Top Pediatric Medicines Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Pediatric Medicines Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Enteral
Table 5. Major Manufacturers of Parenteral
Table 6. Major Manufacturers of Topical
Table 7. Global Pediatric Medicines Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global Pediatric Medicines Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 9. Global Pediatric Medicines Sales by Regions 2015-2020 (K Units)
Table 10. Global Pediatric Medicines Sales Market Share by Regions (2015-2020)
Table 11. Global Pediatric Medicines Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Pediatric Medicines Sales Forecast by Region (2021-2026) (K Units)
Table 13. Global Pediatric Medicines Sales by Manufacturers (2015-2020) (K Units)
Table 14. Global Pediatric Medicines Sales Share by Manufacturers (2015-2020)
Table 15. Global Pediatric Medicines Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Pediatric Medicines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pediatric Medicines as of 2019)
Table 17. Pediatric Medicines Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Pediatric Medicines Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Pediatric Medicines Price (2015-2020) (USD/Unit)
Table 20. Pediatric Medicines Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Pediatric Medicines Product Type
Table 22. Date of International Manufacturers Enter into Pediatric Medicines Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Pediatric Medicines Sales by Type (2015-2020) (K Units)
Table 25. Global Pediatric Medicines Sales Share by Type (2015-2020)
Table 26. Global Pediatric Medicines Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Pediatric Medicines Revenue Share by Type (2015-2020)
Table 28. Pediatric Medicines Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 29. Global Pediatric Medicines Sales Share by Type (2021-2026)
Table 30. Global Pediatric Medicines Sales by Application (2015-2020) (K Units)
Table 31. Global Pediatric Medicines Sales Share by Application (2015-2020)
Table 32. Global Pediatric Medicines Sales Share by Application (2021-2026)
Table 33. Global Pediatric Medicines Sales Market Share Forecast by Application (2021-2026)
Table 34. Global Pediatric Medicines Revenue by Application (2015-2020) (US$ Million)
Table 35. Global Pediatric Medicines Revenue Market Share Forecast by Application (2021-2026)
Table 36. Japan Pediatric Medicines Sales (K Units) of Key Companies (2015-2020)
Table 37. Japan Pediatric Medicines Sales Share by Company (2015-2020)
Table 38. Japan Pediatric Medicines Revenue (US$ Million) by Company (2015-2020)
Table 39. Japan Pediatric Medicines Sales (K Units) by Type (2015-2020)
Table 40. Japan Pediatric Medicines Sales Share by Type (2015-2020)
Table 41. Japan Pediatric Medicines Revenue (US$ Million) Market Share by Type (2015-2020)
Table 42. Japan Pediatric Medicines Price (K Units) by Type (2015-2020)
Table 43. Japan Pediatric Medicines Sales (K Units) by Type (2021-2026)
Table 44. Japan Pediatric Medicines Sales Share by Type (2021-2026)
Table 45. Japan Pediatric Medicines Revenue (US$ Million) Market Share by Type (2021-2026)
Table 46. Japan Pediatric Medicines Revenue Share by Type (2021-2026)
Table 47. Japan Pediatric Medicines Price (K Units) by Type (2021-2026)
Table 48. Japan Pediatric Medicines Sales (K Units) by Application (2015-2020)
Table 49. Japan Pediatric Medicines Sales Share by Application (2015-2020)
Table 50. Japan Pediatric Medicines Revenue (US$ Million) Market Share by Application (2015-2020)
Table 51. Japan Pediatric Medicines Sales (K Units) by Application (2021-2026)
Table 52. Japan Pediatric Medicines Sales Share by Application (2021-2026)
Table 53. Japan Pediatric Medicines Revenue (US$ Million) Market Share by Application (2021-2026)
Table 54. Japan Pediatric Medicines Revenue Share by Application (2021-2026)
Table 55. North America Pediatric Medicines Sales by Country (2015-2020) (K Units)
Table 56. North America Pediatric Medicines Sales Market Share by Country (2015-2020)
Table 57. North America Pediatric Medicines Revenue by Country (2015-2020) (US$ Million)
Table 58. North America Pediatric Medicines Revenue Market Share by Country (2015-2020)
Table 59. Europe Pediatric Medicines Sales by Country (2015-2020) (K Units)
Table 60. Europe Pediatric Medicines Sales Market Share by Country (2015-2020)
Table 61. Europe Pediatric Medicines Revenue by Country (2015-2020) (US$ Million)
Table 62. Europe Pediatric Medicines Revenue Market Share by Country (2015-2020)
Table 63. Asia Pacific Pediatric Medicines Sales by Region (2015-2020) (K Units)
Table 64. Asia Pacific Pediatric Medicines Sales Market Share by Region (2015-2020)
Table 65. Asia Pacific Pediatric Medicines Revenue by Region (2015-2020) (US$ Million)
Table 66. Asia Pacific Pediatric Medicines Revenue Market Share by Region (2015-2020)
Table 67. Latin America Pediatric Medicines Sales by Country (2015-2020) (K Units)
Table 68. Latin America Pediatric Medicines Sales Market Share by Country (2015-2020)
Table 69. Latin Americaa Pediatric Medicines Revenue by Country (2015-2020) (US$ Million)
Table 70. Latin America Pediatric Medicines Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Pediatric Medicines Sales by Country (2015-2020) (K Units)
Table 72. Middle East and Africa Pediatric Medicines Sales Market Share by Country (2015-2020)
Table 73. Middle East and Africa Pediatric Medicines Revenue by Country (2015-2020) (US$ Million)
Table 74. Middle East and Africa Pediatric Medicines Revenue Market Share by Country (2015-2020)
Table 75. GSK Corporation Information
Table 76. GSK Description and Business Overview
Table 77. GSK Pediatric Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. GSK Pediatric Medicines Product
Table 79. GSK Recent Development
Table 80. Novartis Corporation Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis Pediatric Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Novartis Product
Table 84. Novartis Recent Development
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Pediatric Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Pfizer Product
Table 89. Pfizer Recent Development
Table 90. Sanofi Corporation Information
Table 91. Sanofi Description and Business Overview
Table 92. Sanofi Pediatric Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Sanofi Product
Table 94. Sanofi Recent Development
Table 95. Abbott Corporation Information
Table 96. Abbott Description and Business Overview
Table 97. Abbott Pediatric Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Abbott Product
Table 99. Abbott Recent Development
Table 100. Bristol-Myers Squibb Corporation Information
Table 101. Bristol-Myers Squibb Description and Business Overview
Table 102. Bristol-Myers Squibb Pediatric Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Bristol-Myers Squibb Product
Table 104. Bristol-Myers Squibb Recent Development
Table 105. Cipla Corporation Information
Table 106. Cipla Description and Business Overview
Table 107. Cipla Pediatric Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Cipla Product
Table 109. Cipla Recent Development
Table 110. Eisai Pharmaceuticals Corporation Information
Table 111. Eisai Pharmaceuticals Description and Business Overview
Table 112. Eisai Pharmaceuticals Pediatric Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Eisai Pharmaceuticals Product
Table 114. Eisai Pharmaceuticals Recent Development
Table 115. Eli Lilly Corporation Information
Table 116. Eli Lilly Description and Business Overview
Table 117. Eli Lilly Pediatric Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Eli Lilly Product
Table 119. Eli Lilly Recent Development
Table 120. F. Hoffman-La Roche Corporation Information
Table 121. F. Hoffman-La Roche Description and Business Overview
Table 122. F. Hoffman-La Roche Pediatric Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. F. Hoffman-La Roche Product
Table 124. F. Hoffman-La Roche Recent Development
Table 125. Glenmark Corporation Information
Table 126. Glenmark Description and Business Overview
Table 127. Glenmark Pediatric Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Glenmark Product
Table 129. Glenmark Recent Development
Table 130. Helsinn Healthcare Corporation Information
Table 131. Helsinn Healthcare Description and Business Overview
Table 132. Helsinn Healthcare Pediatric Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Helsinn Healthcare Product
Table 134. Helsinn Healthcare Recent Development
Table 135. Heron Therapeutics Corporation Information
Table 136. Heron Therapeutics Description and Business Overview
Table 137. Heron Therapeutics Pediatric Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. Heron Therapeutics Product
Table 139. Heron Therapeutics Recent Development
Table 140. Ipca Laboratories Corporation Information
Table 141. Ipca Laboratories Description and Business Overview
Table 142. Ipca Laboratories Pediatric Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 143. Ipca Laboratories Product
Table 144. Ipca Laboratories Recent Development
Table 145. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 146. Key Challenges
Table 147. Market Risks
Table 148. Main Points Interviewed from Key Pediatric Medicines Players
Table 149. Pediatric Medicines Customers List
Table 150. Pediatric Medicines Distributors List
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Pediatric Medicines Product Picture
Figure 2. Global Pediatric Medicines Sales Market Share by Type in 2020 & 2026
Figure 3. Enteral Product Picture
Figure 4. Parenteral Product Picture
Figure 5. Topical Product Picture
Figure 6. Global Pediatric Medicines Sales Market Share by Application in 2020 & 2026
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Family
Figure 10. Pediatric Medicines Report Years Considered
Figure 11. Global Pediatric Medicines Market Size 2015-2026 (US$ Million)
Figure 12. Global Pediatric Medicines Sales 2015-2026 (K Units)
Figure 13. Global Pediatric Medicines Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Pediatric Medicines Sales Market Share by Region (2015-2020)
Figure 15. Global Pediatric Medicines Sales Market Share by Region in 2019
Figure 16. Global Pediatric Medicines Revenue Market Share by Region (2015-2020)
Figure 17. Global Pediatric Medicines Revenue Market Share by Region in 2019
Figure 18. Global Pediatric Medicines Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Pediatric Medicines Revenue in 2019
Figure 20. Pediatric Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Pediatric Medicines Sales Market Share by Type (2015-2020)
Figure 22. Global Pediatric Medicines Sales Market Share by Type in 2019
Figure 23. Global Pediatric Medicines Revenue Market Share by Type (2015-2020)
Figure 24. Global Pediatric Medicines Revenue Market Share by Type in 2019
Figure 25. Global Pediatric Medicines Market Share by Price Range (2015-2020)
Figure 26. Global Pediatric Medicines Sales Market Share by Application (2015-2020)
Figure 27. Global Pediatric Medicines Sales Market Share by Application in 2019
Figure 28. Global Pediatric Medicines Revenue Market Share by Application (2015-2020)
Figure 29. Global Pediatric Medicines Revenue Market Share by Application in 2019
Figure 30. Japan Pediatric Medicines Sales Growth Rate 2015-2026 (K Units)
Figure 31. Japan Pediatric Medicines Revenue Growth Rate 2015-2026 (US$ Million)
Figure 32. Japan Pediatric Medicines Market Share in Global Market 2015-2026
Figure 33. Japan 5 and 10 Largest Pediatric Medicines Players Market Share by Revenue in Pediatric Medicines in 2019
Figure 34. Japan Pediatric Medicines Revenue Share by Type (2015-2020)
Figure 35. Japan Pediatric Medicines Revenue Growth Rate by Type in 2015 & 2019
Figure 36. Japan Pediatric Medicines Revenue Share by Application (2015-2020)
Figure 37. Japan Pediatric Medicines Revenue Growth Rate by Application in 2015 & 2019
Figure 38. North America Pediatric Medicines Sales Growth Rate 2015-2020 (K Units)
Figure 39. North America Pediatric Medicines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. North America Pediatric Medicines Sales Market Share by Country in 2019
Figure 41. North America Pediatric Medicines Revenue Market Share by Country in 2019
Figure 42. U.S. Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 43. U.S. Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Canada Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 45. Canada Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. Europe Pediatric Medicines Sales Growth Rate 2015-2020 (K Units)
Figure 47. Europe Pediatric Medicines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 48. Europe Pediatric Medicines Sales Market Share by Country in 2019
Figure 49. Europe Pediatric Medicines Revenue Market Share by Country in 2019
Figure 50. Germany Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 51. Germany Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. France Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 53. France Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. U.K. Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 55. U.K. Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Italy Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 57. Italy Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Russia Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 59. Russia Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Asia Pacific Pediatric Medicines Sales Growth Rate 2015-2020 (K Units)
Figure 61. Asia Pacific Pediatric Medicines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Pediatric Medicines Sales Market Share by Region in 2019
Figure 63. Asia Pacific Pediatric Medicines Revenue Market Share by Region in 2019
Figure 64. China Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 65. China Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 67. Japan Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 69. South Korea Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 71. India Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 73. Australia Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 75. Taiwan Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 77. Indonesia Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 79. Thailand Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 81. Malaysia Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 83. Philippines Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 85. Vietnam Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Latin America Pediatric Medicines Sales Growth Rate 2015-2020 (K Units)
Figure 87. Latin America Pediatric Medicines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Pediatric Medicines Sales Market Share by Country in 2019
Figure 89. Latin America Pediatric Medicines Revenue Market Share by Country in 2019
Figure 90. Mexico Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 91. Mexico Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 93. Brazil Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 95. Argentina Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Middle East and Africa Pediatric Medicines Sales Growth Rate 2015-2020 (K Units)
Figure 97. Middle East and Africa Pediatric Medicines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Pediatric Medicines Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Pediatric Medicines Revenue Market Share by Country in 2019
Figure 100. Turkey Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 101. Turkey Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 103. Saudi Arabia Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 105. U.A.E Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Porter's Five Forces Analysis
Figure 107. Pediatric Medicines Value Chain
Figure 108. Channels of Distribution
Figure 109. Distributors Profiles
Figure 110. Bottom-up and Top-down Approaches for This Report
Figure 111. Data Triangulation
Figure 112. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs